SEDATIVE
Drugs that calm the patient and reduce anxiety without inducing
normal sleep.
HYPNOTICS
Drugs that produce drowsiness and encourage the
onset of sleep
CLASSIFICATION OF DRUGS
 Barbiturates.
 Benzodiazepines ( BDZ ).
 Miscellaneous agents.
 Buspirone
 Chloral hydrate
 Zolpidem
 Zaleplon.
 zopiclon
BARBITURATES
 Are CNS depressants which produce effects rangingfrom
Hypnosis
 Sedation
and
Reduction of anxiety
Unconsciousness.
 Barbiturates were in the past the mainstayof treatment.
BARBITURATES
Short-acting(3-8h):
• Pentobarbitone
• Secobarbitone
• Amobarbital
Ultrashort acting (25 minutes): Thiopentone, Methohexitone.
Classification:
Long acting( 24-28 h): Phenobarbitone
Intermediate (8-24h): Amylobarbitone
Bayeredicoverer
of barbiturates.
MECHANISM OFACTION
 GABAthe major inhibitory neurotransmitter in the
brain.
 It has specific receptors in chloridechannels present
on the membrane of post synapticneurons.
 regulates theentrance
of chloride into the
postsynapticcells.
MECHANISM OFACTION
 Binding of GABA to its receptor (GABA A receptor)
 Results in opening of thechloride channel and
  Increased conductance of cl¯ ions to insidethe
post-synaptic neuron.  hyperpolarization of the
postsynaptic neuronand
  decreased synapticneurotransmission.
MECHANISM OF ACTION
 Barbituratesincreases the cl¯ ion channel opening
(at higher doses open cl¯ ion channels and block Na+
channels)
  Increased conductance of cl¯ ions to insidethe
post-synaptic neuron.  hyperpolarization of the
postsynaptic neuronand
  decreased synapticneurotransmission.
PHARMACOLOGICALACTIONS
At Low Doses :
Barbiturates produce sedation
At Higher Doses :
 Produce hypnosis Anaesthesia.
Overdosage may cause respiratory
depression and death.
USES
 ANTICONVULSANT: Phenobarbitone. (tonic-cronic seizures
and eclampsia)
 INDUCTION OF ANESTHESIA: thiopentone and
methohexitone.
HYPNOTIC: pentobarbital (used as sleeping pills).
HYPERBILIRUBINEMIA : pentobarbital
To lower serum bilirubin :
a) Patients with chronic cholestasis
b) Neonatal jaundice (kernicterus)
ADVERSE EFFECTS
 Respiratory depression.
 Hangover: residual sedation after awakening.
 Tolerance.
 Physical dependence with prolonged use.
 Teratogenicity.
 Allergic reaction: urticaria and skin rash.
Toxicity : Respiratory depression, Cardiovascular collapse, coma
and death.
BENZODIZEPINES
 The most widely used anxiolyticdrugs.
 They have largely replaced barbiturates inthe
treatment of anxiety,
Since
 BZs are more effective andsafer.
 BZs inducesleep when given in highdoses at
night.
 provide sedation.
 reduce anxiety when given in low,divided
doses during theday.
BENZODIZEPINES
 Sedative (Anxiolytics) :
Alprazolam
Diazepam
Chlordiazepoxide lorazepam
lorazepam
 Hypnotics :
Triazolam
Lorazepam
Diazepam
Estazolam
Alprazolam
Temazepam
Flurazepam Nitrazepam Quazepam
 Preanesthetics :
Diazepam - Midazolam
Leosternback
MECHANISM OF ACTION
 GABAthe major inhibitory neurotransmitter in the
brain.
 It has specific receptors in chloridechannels present
on the membrane of postsynaptic neurons.
 regulates theentrance
of chloride into the
postsynapticcells.
MECHANISM OF ACTION
 BZs bind to specific, high affinity BZreceptors
present in CNS.
 These receptors are separate but adjacent to the
receptor forGABA.
 The binding of BZ enhances the affinityof the
GABA receptors for GABAneurotransmitter.
 Resulting in a more frequent opening ofadjacent
chloridechannels.
 The increased influx of Cl- into the neuronresults
in enhanced.
 Hyperpolarization and inhibition of neuronal
firing
Therapeutic uses
ANXIETY DISORDERS : alprazolam, lorazepam,
lorazepam, diazepam and chlordiazepoxide.
Alprazolam has anxiolytic-antidepressant effect.
Diazepam is preferred in acute panic-anxiety.
Chlordiazepoxide is preferred in chronic anxiety states.
Therapeutic uses
INSOMNIA : in ability to sleep.
Triazolam, lorazepam is effective in treating individuals
who have difficulty in going sleep.
Flurazepam, temazepam & nitrazepam is useful for
insomnia caused by inability to stay asleep.
Therapeutic uses
To control withdrawal symptoms of alcohols
diazepam- chlordiazepoxide.
Anticonvulsants:
 Diazepam – Lorazepam: Status epilepticus
 Clonazepam-Clorazepate: in chronic treatment of epilepsy.
Muscle relaxation: in spastic states (Diazepam) .
Therapeutic uses
InAnesthesia :
Preanesthetic medication diazepam
Induction of balanced anesthesia (Midazolam)
ADVERSE EFFECTS
 Ataxia (motor incoordination), cognitive impairment.
 Hangover, drowsiness, confusion (especially in long acting
drugs)
 Tolerance
 Physical and Psychological dependence (in high doses)
 Withdrawal symptoms (Abrupt discontinuation of BZs)
 Insomnia, anorexia, anxiety, agitation, tremors
and convulsion.(Abrupt discontinuation of BZs)
Barbiturates
Structure Activity Relationship (SAR) of
Barbiturates
• 1)Both hydrogen atoms in position 5 of
barbituric acid must be replaced for
maximal activity.
2)Increasing the length of an alkyl chain in the 5
position enhances potency up to 5 or 6 carbon
atoms.
3)Branched, cyclic or unsaturated in the 5 position
generally produce a briefer duration of action than
do normal saturated chains containing the same
number of carbon atoms.
4)Compounds with alkyl groups in the 1 or 3
position may have a shorter onset & duration of
action.
5)Replacement of oxygen by sulfur on the 2 carbon
shortens onset & duration of action.
These are the Structure-Activity-Relationship of
barbiturates.
SAR of benzodiazepines
1.The presence of an electron attracting
substituent at position 7 is required for activity
2. Position 6,8 and 9 should not be substituted .
3.A phenyl group at the 5 position promotes activity if
this group is orthoor di ortho substituted with electron
attracting groups , activity is increased.
On the other hand ,para substitution decreases activity
greatly.
5.The 2 carbonyl function is optimal for activity as in
the nitrogen atom at 1 position .
6.The N-substituent should be small .

Sedative hypnotics.pptx

  • 2.
    SEDATIVE Drugs that calmthe patient and reduce anxiety without inducing normal sleep.
  • 3.
    HYPNOTICS Drugs that producedrowsiness and encourage the onset of sleep
  • 4.
    CLASSIFICATION OF DRUGS Barbiturates.  Benzodiazepines ( BDZ ).  Miscellaneous agents.  Buspirone  Chloral hydrate  Zolpidem  Zaleplon.  zopiclon
  • 5.
    BARBITURATES  Are CNSdepressants which produce effects rangingfrom Hypnosis  Sedation and Reduction of anxiety Unconsciousness.  Barbiturates were in the past the mainstayof treatment.
  • 6.
    BARBITURATES Short-acting(3-8h): • Pentobarbitone • Secobarbitone •Amobarbital Ultrashort acting (25 minutes): Thiopentone, Methohexitone. Classification: Long acting( 24-28 h): Phenobarbitone Intermediate (8-24h): Amylobarbitone Bayeredicoverer of barbiturates.
  • 7.
    MECHANISM OFACTION  GABAthemajor inhibitory neurotransmitter in the brain.  It has specific receptors in chloridechannels present on the membrane of post synapticneurons.  regulates theentrance of chloride into the postsynapticcells.
  • 8.
    MECHANISM OFACTION  Bindingof GABA to its receptor (GABA A receptor)  Results in opening of thechloride channel and   Increased conductance of cl¯ ions to insidethe post-synaptic neuron.  hyperpolarization of the postsynaptic neuronand   decreased synapticneurotransmission.
  • 9.
    MECHANISM OF ACTION Barbituratesincreases the cl¯ ion channel opening (at higher doses open cl¯ ion channels and block Na+ channels)   Increased conductance of cl¯ ions to insidethe post-synaptic neuron.  hyperpolarization of the postsynaptic neuronand   decreased synapticneurotransmission.
  • 10.
    PHARMACOLOGICALACTIONS At Low Doses: Barbiturates produce sedation At Higher Doses :  Produce hypnosis Anaesthesia. Overdosage may cause respiratory depression and death.
  • 11.
    USES  ANTICONVULSANT: Phenobarbitone.(tonic-cronic seizures and eclampsia)  INDUCTION OF ANESTHESIA: thiopentone and methohexitone. HYPNOTIC: pentobarbital (used as sleeping pills). HYPERBILIRUBINEMIA : pentobarbital To lower serum bilirubin : a) Patients with chronic cholestasis b) Neonatal jaundice (kernicterus)
  • 12.
    ADVERSE EFFECTS  Respiratorydepression.  Hangover: residual sedation after awakening.  Tolerance.  Physical dependence with prolonged use.  Teratogenicity.  Allergic reaction: urticaria and skin rash. Toxicity : Respiratory depression, Cardiovascular collapse, coma and death.
  • 13.
    BENZODIZEPINES  The mostwidely used anxiolyticdrugs.  They have largely replaced barbiturates inthe treatment of anxiety, Since  BZs are more effective andsafer.  BZs inducesleep when given in highdoses at night.  provide sedation.  reduce anxiety when given in low,divided doses during theday.
  • 14.
    BENZODIZEPINES  Sedative (Anxiolytics): Alprazolam Diazepam Chlordiazepoxide lorazepam lorazepam  Hypnotics : Triazolam Lorazepam Diazepam Estazolam Alprazolam Temazepam Flurazepam Nitrazepam Quazepam  Preanesthetics : Diazepam - Midazolam Leosternback
  • 15.
    MECHANISM OF ACTION GABAthe major inhibitory neurotransmitter in the brain.  It has specific receptors in chloridechannels present on the membrane of postsynaptic neurons.  regulates theentrance of chloride into the postsynapticcells.
  • 16.
    MECHANISM OF ACTION BZs bind to specific, high affinity BZreceptors present in CNS.  These receptors are separate but adjacent to the receptor forGABA.  The binding of BZ enhances the affinityof the GABA receptors for GABAneurotransmitter.  Resulting in a more frequent opening ofadjacent chloridechannels.  The increased influx of Cl- into the neuronresults in enhanced.  Hyperpolarization and inhibition of neuronal firing
  • 17.
    Therapeutic uses ANXIETY DISORDERS: alprazolam, lorazepam, lorazepam, diazepam and chlordiazepoxide. Alprazolam has anxiolytic-antidepressant effect. Diazepam is preferred in acute panic-anxiety. Chlordiazepoxide is preferred in chronic anxiety states.
  • 18.
    Therapeutic uses INSOMNIA :in ability to sleep. Triazolam, lorazepam is effective in treating individuals who have difficulty in going sleep. Flurazepam, temazepam & nitrazepam is useful for insomnia caused by inability to stay asleep.
  • 19.
    Therapeutic uses To controlwithdrawal symptoms of alcohols diazepam- chlordiazepoxide. Anticonvulsants:  Diazepam – Lorazepam: Status epilepticus  Clonazepam-Clorazepate: in chronic treatment of epilepsy. Muscle relaxation: in spastic states (Diazepam) .
  • 20.
    Therapeutic uses InAnesthesia : Preanestheticmedication diazepam Induction of balanced anesthesia (Midazolam)
  • 21.
    ADVERSE EFFECTS  Ataxia(motor incoordination), cognitive impairment.  Hangover, drowsiness, confusion (especially in long acting drugs)  Tolerance  Physical and Psychological dependence (in high doses)  Withdrawal symptoms (Abrupt discontinuation of BZs)  Insomnia, anorexia, anxiety, agitation, tremors and convulsion.(Abrupt discontinuation of BZs)
  • 22.
  • 23.
    Structure Activity Relationship(SAR) of Barbiturates • 1)Both hydrogen atoms in position 5 of barbituric acid must be replaced for maximal activity. 2)Increasing the length of an alkyl chain in the 5 position enhances potency up to 5 or 6 carbon atoms. 3)Branched, cyclic or unsaturated in the 5 position generally produce a briefer duration of action than do normal saturated chains containing the same number of carbon atoms.
  • 24.
    4)Compounds with alkylgroups in the 1 or 3 position may have a shorter onset & duration of action. 5)Replacement of oxygen by sulfur on the 2 carbon shortens onset & duration of action. These are the Structure-Activity-Relationship of barbiturates.
  • 26.
    SAR of benzodiazepines 1.Thepresence of an electron attracting substituent at position 7 is required for activity 2. Position 6,8 and 9 should not be substituted . 3.A phenyl group at the 5 position promotes activity if this group is orthoor di ortho substituted with electron attracting groups , activity is increased. On the other hand ,para substitution decreases activity greatly. 5.The 2 carbonyl function is optimal for activity as in the nitrogen atom at 1 position . 6.The N-substituent should be small .